Expert-led webinars that connect life sciences leaders with the insights, solutions and partners they need to move their work forward.
Developability Assessment and Early Formulation Studies for Biologics
Candidate selection, biophysical characterisation and pre-formulation screening to reduce late stage failures and build a strong data foundation.
27/02/2025
EU GMP Annex 1: New Standards for Injectable Drug Manufacturing
Revised EMA GMP Annex 1 guidelines, impact on contamination control strategy and the role of primary packaging suppliers in sterility assurance.
08/04/2025
Advancements in On-Body Drug Delivery Systems: Overcoming Challenges and Driving Innovation
Advances in on-body delivery for high volume and viscous drugs, with strategies for optimising platforms from prototype through to clinical readiness.
10/04/2025
Overcoming Challenges in Preclinical Studies for Intranasal and Inhalation Programs
Preclinical intranasal and inhalation protocols, covering system selection, animal model design, insufflator and micro sprayer technologies.
29/05/2025
Unlocking the Future of Drug Development: How PBBM & Solid Form Screening Drive Early-Phase Success
Solid form screening, PBBM modelling and in vitro testing to identify absorption risks, guide form selection and accelerate early phase development.
05/06/2025
Navigating the sterile fill finish CDMO landscape for development and manufacturing success
CDMO capability assessment, facility design, EU GMP Annex 1 compliance and formulation strategies for sterile liquid and powder drug products.
25/06/2025
Targeting the Airways: Innovations in Soft Mist Drug Delivery for All Ages – Including Infants
Soft mist aerosol technology for targeted respiratory deposition across all age groups, including a pacifier-based delivery interface designed for infants.
09/07/2025
Smarter Drug Development for Biologics with In Silico Modelling
Computational approaches to biologics developability, formulation optimisation and stability prediction, with case studies on risk reduction.
01/07/2025
Unlocking Therapeutic Potential Through Nasal Drug Repositioning
Evaluating nasal repositioning potential, covering clinical suitability, regulatory strategy, delivery system selection and commercial impact.
13/11/2025
Could Transmucosal Delivery Be the Right Route for Your API?
API requirements for transmucosal delivery, Mucofilm compatibility and key development steps from feasibility through to commercial manufacture.
10/09/2025
Managing the uncertainty in treatment exposure to increase success in clinical trials
Digital adherence monitoring, RBQM integration and the estimand framework to reduce trial variability and strengthen exposure response analysis.
16/09/2025
Holistic approach to Intravitreal Injection combining Packaging and Device
The full value chain for intravitreal injection, from primary packaging and coating technology to filtered needle selection and USP 789 particle compliance.
18/09/2025
Nose-to-Brain Drug Delivery and Device Selection
Key delivery targets, transport mechanisms and device considerations for nose to brain CNS delivery, from formulation to regulatory submission.
01/10/2025
Subvisible Particle Analysis: Ensuring Quality from Lab Bench to GMP
Regulatory requirements, method validation and variability control for subvisible particle analysis from R&D through to GMP compliance.
18/11/2025
Scaling Up Oral Solid Dose Manufacturing for Late-Phase Success
How to select the right CDMO, translate lab data into scalable OSD processes and apply QbD principles to avoid delays in late-phase manufacturing.
25/03/2026
Hugo-Nano: The Next Generation of Fully Human VHH Nanobodies
HUGO-Nano mouse generates fully human, developable single-domain antibodies (VHHs) with no post-discovery humanization required.
19/11/2026
Advancing Autoinjector Platforms for Evolving Drug and Patient Needs
How adaptable platform technology can address diverse drug profiles, patient needs and brand requirements without starting device development from scratch.
07/12/2026
Developing Nasal Drug Delivery's Next Generation: Psychedelics and CNS
How formulation and manufacturing strategies are evolving to support nasal drug delivery's expansion beyond traditional local and systemic therapies
09/12/2026
Moving circularity forward in medical device packaging
Learn how Tyvek® with Renewable Attribution is helping accelerate circularity in medical device packaging.
24/11/2026
Feasibility to Phase I: How Early Development Decisions Save Time and Cost
Discover how to assess API suitability for oral films and transdermal patches, reduce time and cost, and optimise formulations
17/09/2026
Paving the way to a successful AAV product
Analytical methods for AAV characterisation, quality attributes for manufacturing and orthogonal approaches for infectivity and capsid ratios.
20/11/2024
Sharpening the Future: New Opportunities for Implant Injection
Drug implant technology advances, applicator design, manufacturing quality standards and market opportunities for long acting implant systems.
01/10/2024
Lyo-Modelling Reduce risks on the road to commercialization through process understanding
Lyophilisation modelling for primary drying optimisation, robustness analysis and in silico assessment of process failures to ensure product quality.
10/07/2024
Shedding light on surfactants used as excipient for biologics
Polysorbate degradation mechanisms, surfactant characterisation strategies and multidimensional chromatography for surfactant analysis in biologics.
07/05/2024
Road To Success: Mapping drug development from preclinical to commercialization
A phase appropriate development roadmap for biologics, covering formulation, analytical characterisation and derisking from preclinical to market.
21/02/2024
Every particle matters
Particle identification and characterisation tools for biologics and cell and gene therapy, covering origins, analytical methods and troubleshooting.
29/11/2023
Formulating the Future:
Nucleic Acid Therapeutics Explained
Critical quality attributes for mRNA-LNP formulations, LNP delivery system stability and the analytical toolbox for nucleic acid therapeutics.
05/03/2026
Characterize Your Biologics with Smart and Science-driven Concepts
How to choose the best panel of phase-appropriate analytical methods for complex modalities while maintaining aggressive development timelines
09/07/2026
Simplifying ADC Development: An Integrated Path from Concept to Commercialization
Best practices for scalable ADC manufacturing, end to end integration and reducing complexity across the full ADC development lifecycle.
25/06/2026
Sterile Drug Products: Phase I Development in a Post-Annex 1 Environment
Annex 1 has raised the bar for sterile drug product development. A structured single-site approach could be the fastest route to Phase I.
23/07/2026
Hypodermic Needle
Secure your Value Proposition
by Co-Packing
Needle choice is rarely a headline decision, yet it contributes to the treatment experience and efficacy.
24/09/2026
Transitioning an Oral Solid Dosage from Phase 1 to Phase 2 studies: Formulation challenges and strategies
Development timelines, formulation optimisation strategies and CDMO selection for transitioning oral solid dosage forms from Phase 1 to Phase 2.
26/02/2025
How RTU Solutions Can Meet GMP Annex 1 Requirements
Pre-sterilised ready to use containers as a compliant aseptic solution, reducing contamination risk and simplifying EU GMP Annex 1 compliance.
14/11/2024
Unlocking Success in Inhaled & Nasal Drug Clinical Studies
Critical factors in OINDP clinical development, CMC risk mitigation and how to balance preparation levels to meet regulatory expectations.
22/10/2024
Innovative Solutions in Pre-Filled Syringes for Biologics and Ophthalmic Applications
Selecting the right pre-filled syringe for biologics and ophthalmic applications, covering plasma coating, viscosity, compatibility and analytics.
11/07/2024
Preservative-Free Spray Applications and Their Compliant Road to Market
Preservative-free spray system options, drug device combination under EU MDR and regulatory documentation requirements for market entry.
27/06/2024
Master the Next Generation of Clinical Research: 5 Strategies to Dramatically Improve Data Quality
Five strategies for clinical data quality, covering data management, risk based quality management, AI assisted review and proactive error detection.
08/05/2024
Packaging Precision: Insights on Ensuring Stability and Shelf-Life
Capsule and packaging material selection for OSD formulations, strategies for overcoming stability challenges and cost optimisation during scale up.
07/03/2024
17/09/2026
23/07/2026
09/07/2026
25/06/2026
18/11/2025
13/11/2025
16/09/2025
18/09/2025
09/07/2025
25/06/2025
29/05/2025
05/06/2025
21/02/2024
08/05/2024
10/04/2025
11/07/2024
10/07/2024
27/02/2025
26/02/2025
We deliver end-to-end webinar programmed for Pharma, biotech and medtech organizations. From understanding your objectives and identifying the right audiences, to expert-led content, targeted promotion and effective follow-up.
We help you reach the right people with precision. Through audience insight and data-driven targeting we attract high quality registration from decision makers who are relevant to your objectives.
Webinar campaigns combine targeted email nurture sequences, personalised LinkedIn outreach to key prospects, and strategic telemarketing to drive awareness, registration and attendance across channels.
Webinar delivery encompasses live presentation management, speaker coordination, attendee engagement through Q&A and polls, technical support, recording capture, and real-time issue resolution for seamless execution
Audience engagement and follow-up involves real-time interaction during the webinar, post-event feedback collection, personalised outreach to attendees, and strategic nurture sequences to drive conversion.
We connect you with engaged life sciences professionals across Pharma, biotech and medtech.
High-quality, independent content developed with industry experts and trusted by your peers.
Our webinars deliver exceptional engagement, with an average engagement rate of 42%.
From strategy and promotion to delivery and follow-up. we handle every detail.
Expert-led webinars that connect life sciences leaders with the insights, solutions and partners they need to move their work forward.
